Where One Lives Impacts Dementia Risk
By Lori Solomon HealthDay Reporter
FRIDAY, Dec. 13, 2024 -- Neighborhood disadvantage is more strongly associated with measures of cardiometabolic health and cognition in individuals without mild cognitive impairment (MCI) compared to those with MCI, according to a study published online Dec. 6 in Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring.
Sudarshan Krishnamurthy, from the Wake Forest University School of Medicine in Winston-Salem, North Carolina, and colleagues investigated the relationship between neighborhood disadvantage with measures of cardiometabolic health and cognition. Analysis included 537 adults (aged >55 years) participating in the Wake Forest Alzheimer's Disease Research Center Healthy Brain Study (between 2016 and 2021); 39.3 percent had MCI.
The researchers found that Area Deprivation Index (ADI) was positively associated with blood pressure and cardiometabolic index (CMI). There was a negative association between ADI and global and Preclinical Alzheimer's Cognitive Composite scores in cognitively unimpaired individuals. In individuals with MCI, ADI was only positively associated with hemoglobin A1c.
"Neighborhood disadvantage is associated more strongly with measures of cardiometabolic health and cognition among cognitively unimpaired individuals rather than MCI," the authors write. "These findings demonstrate a need for structural solutions to address social determinants of health in an attempt to reduce cardiometabolic and cognitive risks."
One author disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
2015 to 2021 Saw Decrease in Incidence of Dementia
FRIDAY, May 23, 2025 -- From 2015 to 2021, there was a decrease in the incidence of dementia, but an increase in prevalence, according to a study published online May 20 in The...
Herpes Simplex Virus Type 1 May Affect Risk for Alzheimer Disease
THURSDAY, May 22, 2025 -- Herpes simplex virus type 1 (HSV-1) is associated with an increased risk for Alzheimer disease (AD) based on real-world data from the United States...
Exposure to Certain HIV Drugs May Significantly Lower Risk for Alzheimer Disease
TUESDAY, May 20, 2025 -- Exposure to nucleoside reverse transcriptase inhibitors (NRTIs), which treat HIV and hepatitis B and inhibit inflammasome activation, is associated with a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.